The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.
The campaigns also claim the product can prevent spread of MRSA and norovirus.
The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act.
The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.
Safety Synergy: Infection Prevention That Protects Patients and Workers
Prefabricated Wall Panels Speed UCF Lake Nona Medical Center Construction
New Dallas Pediatric Campus Reaches Topping-Out Milestone
Hospitals Are Energy Super-Users. Why Is It So Hard to Modernize Them?
Encompass Health Rehabilitation Hospital of Bangor Officially Opens